Lived experience and diabetes technology
The Diabetes Australia Grand Innovation Challenge launches today and it’s tackling something the sector desperately needs. Australia is in short supply of […]
Category: News
MFN 2.0: How the US GENEROUS model could quietly reshape global pricing and put Australia on the back foot
On 6 November 2025, the US Centers for Medicare & Medicaid Services (CMS) announced the GENEROUS (GENErating cost Reductions fOr US Medicaid) […]
What pharma companies need to know about the new PBS Notice of Intent requirements
The Department of Health, Disability and Ageing has announced changes to their PBS Notice of Intent (NOI) process that will impact your […]
We’ve joined the National AI Centre’s AI Directory
Exciting news! Pulse Economics is proud to be listed on the National AI Centre’s AI Directory, a platform showcasing Australia’s AI capabilities […]
Future proofing HTA: critical conversations for Australian healthcare
Key challenges and opportunities shaping health technology assessment Next Tuesday’s ISPOR workshop brings together Australia’s leading HTA stakeholders: PBAC members, HTA Review […]
Kosi Challenge – March 2025
This weekend, our Pulse Economics team took on the Kosi Challenge, climbing Mt Kosciuszko to shine a light on rare cancers. We’re […]
Free market access strategy advisory for medtech startups
Pulse Economics is offering free 30-minute consultations to help you navigate the complexities of market access and reimbursement in Australia. Gain insights […]
HTA careers in the MedTech Sector
I am thrilled to have had the opportunity to speak at the ARCS Australia Conference 2024! It was an honour to share […]
Australian Comprehensive Cancer Network (ACCN) Launch
On behalf of health economists, thank you to Cancer Australia for launching the Australian Comprehensive Cancer Network (ACCN)! At yesterday’s Innovation Showcase, research groups […]
Medicines Australia Horizon Scanning Forum
Our Medicines Australia Horizon Scanning Forum presentation highlighted the journey of AI-enabled IVD from Parkinson’s prognosis to broader neurological applications. As advancements […]